IN2012DN03178A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03178A IN2012DN03178A IN3178DEN2012A IN2012DN03178A IN 2012DN03178 A IN2012DN03178 A IN 2012DN03178A IN 3178DEN2012 A IN3178DEN2012 A IN 3178DEN2012A IN 2012DN03178 A IN2012DN03178 A IN 2012DN03178A
- Authority
- IN
- India
- Prior art keywords
- particulate system
- binds
- targets
- tissues
- substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
- A61K47/6929—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle
- A61K47/6931—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer
- A61K47/6935—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores the form being a nanoparticle, e.g. an immuno-nanoparticle the material constituting the nanoparticle being a polymer the polymer being obtained otherwise than by reactions involving carbon to carbon unsaturated bonds, e.g. polyesters, polyamides or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24753509P | 2009-09-30 | 2009-09-30 | |
PCT/US2010/050846 WO2011041496A1 (en) | 2009-09-30 | 2010-09-30 | Phototriggered nanoparticles for cell and tissue targeting |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN03178A true IN2012DN03178A (pt) | 2015-09-25 |
Family
ID=43826645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3178DEN2012 IN2012DN03178A (pt) | 2009-09-30 | 2010-09-30 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20130004522A1 (pt) |
EP (1) | EP2482922A1 (pt) |
KR (1) | KR20120080615A (pt) |
CN (1) | CN102883773A (pt) |
AU (1) | AU2010300629A1 (pt) |
BR (1) | BR112012009182A2 (pt) |
CA (1) | CA2780137C (pt) |
IL (1) | IL218964A0 (pt) |
IN (1) | IN2012DN03178A (pt) |
MX (1) | MX2012003990A (pt) |
RU (1) | RU2012117418A (pt) |
WO (1) | WO2011041496A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2362878T3 (es) | 2003-07-17 | 2011-07-14 | Unilever N.V. | Procedimiento para la preparación de una dispersión comestible que comprende aceite y agente estructurante. |
WO2006087090A1 (en) | 2005-02-17 | 2006-08-24 | Unilever N.V. | Granules comprising sterol |
US20110218123A1 (en) | 2008-09-19 | 2011-09-08 | President And Fellows Of Harvard College | Creation of libraries of droplets and related species |
PL2367434T3 (pl) | 2008-12-19 | 2017-09-29 | Unilever BCS Europe B.V. | Jadalne tłuszczowe proszki |
CA2802616C (en) | 2010-06-22 | 2018-07-10 | Unilever Plc | Edible fat powders |
MX337914B (es) | 2010-12-17 | 2016-03-28 | Unilever Nv | Proceso para compactar polvo de grasa microporosa y polvo de grasa compactado asi obtenido. |
US8993035B2 (en) | 2010-12-17 | 2015-03-31 | Conopco, Inc. | Edible water in oil emulsion |
US20160279068A1 (en) * | 2013-11-08 | 2016-09-29 | President And Fellows Of Harvard College | Microparticles, methods for their preparation and use |
CN103623417B (zh) * | 2013-12-18 | 2016-01-20 | 东华大学 | 一种功能化聚酰胺-胺树状大分子的纳米复合物的应用 |
AU2016338907B2 (en) | 2015-10-13 | 2022-07-07 | President And Fellows Of Harvard College | Systems and methods for making and using gel microspheres |
CN114574187B (zh) * | 2020-11-30 | 2024-03-05 | 北京京东方技术开发有限公司 | 纳米粒子、纳米粒子层图案化的方法及相关应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998580A (en) * | 1995-10-13 | 1999-12-07 | Fay; Frederick F. | Photosensitive caged macromolecules |
US20070041934A1 (en) * | 2005-08-12 | 2007-02-22 | Regents Of The University Of Michigan | Dendrimer based compositions and methods of using the same |
US20080318246A1 (en) * | 2007-03-07 | 2008-12-25 | The Albert Einstein College Of Medicine Of Yeshiva University | Deeply quenched enzyme sensors |
-
2010
- 2010-09-30 CN CN2010800538264A patent/CN102883773A/zh active Pending
- 2010-09-30 IN IN3178DEN2012 patent/IN2012DN03178A/en unknown
- 2010-09-30 US US13/499,543 patent/US20130004522A1/en not_active Abandoned
- 2010-09-30 EP EP10821224A patent/EP2482922A1/en not_active Withdrawn
- 2010-09-30 MX MX2012003990A patent/MX2012003990A/es not_active Application Discontinuation
- 2010-09-30 BR BR112012009182A patent/BR112012009182A2/pt not_active IP Right Cessation
- 2010-09-30 RU RU2012117418/15A patent/RU2012117418A/ru not_active Application Discontinuation
- 2010-09-30 CA CA2780137A patent/CA2780137C/en not_active Expired - Fee Related
- 2010-09-30 AU AU2010300629A patent/AU2010300629A1/en not_active Abandoned
- 2010-09-30 KR KR1020127010831A patent/KR20120080615A/ko not_active Application Discontinuation
- 2010-09-30 WO PCT/US2010/050846 patent/WO2011041496A1/en active Application Filing
-
2012
- 2012-04-01 IL IL218964A patent/IL218964A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2012003990A (es) | 2012-06-27 |
BR112012009182A2 (pt) | 2018-03-20 |
WO2011041496A1 (en) | 2011-04-07 |
AU2010300629A1 (en) | 2012-06-21 |
US20130004522A1 (en) | 2013-01-03 |
CN102883773A (zh) | 2013-01-16 |
KR20120080615A (ko) | 2012-07-17 |
EP2482922A1 (en) | 2012-08-08 |
IL218964A0 (en) | 2012-06-28 |
CA2780137A1 (en) | 2011-04-07 |
CA2780137C (en) | 2014-07-22 |
RU2012117418A (ru) | 2013-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN03178A (pt) | ||
EP2569330A4 (en) | CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF | |
CO6571886A2 (es) | Antagonistas de pcsk9 | |
BRPI0917017B8 (pt) | inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos | |
MY159396A (en) | Compositions and methods for antibodies targeting complement protein c5 | |
AU328719S (en) | Lighting device | |
AU323335S (en) | Funnel | |
MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
MY161868A (en) | Anti-bv8 antibodies and uses thereof | |
AU331651S (en) | Lighting device | |
AU316948S (en) | Toothbrush | |
AU323419S (en) | Teething device | |
IN2012DN01538A (pt) | ||
EP2597949A4 (en) | SUBMIKROMETERZUSAMMENSETZUNGEN | |
EP3150632A3 (en) | Anti-ricin antibodies and uses thereof | |
DE502008001951D1 (de) | Axomadol zur schmerzbehandlung bei arthrose | |
CL2012000355A1 (es) | Compuestos derivados de 4-amino-butenamida; composicion farmaceutica; y uso en el tratamiento de la epoc. | |
BRPI0919176A2 (pt) | composição farmacêutica com intensidade iônica relativamente baixa. | |
UA44395U (ru) | Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении | |
UA92646C2 (ru) | применение производных 2-оксоиндолин-3-глиоксиловой кислоты в качестве средств с актопротекторным действием | |
AU331653S (en) | Lighting device | |
AU331652S (en) | Lighting device | |
AU325094S (en) | Lamp (par16 e14-1) | |
AU325097S (en) | Lamp (AR111-1) | |
AU325096S (en) | Lamp (par16 GU10-1) |